Al RNE. Safet y and efficacy of first -line nivolumab and ipilimumab in non -small cell lung cancer. Presented at: 16thWorld Conference on L ung Cancer. CO, USA, (Abstract ORAL 02.05.) 6 –9 September 2015. 83.